U.S. arthritis prevalence continues steady rise; activity limitations grow more rapidlyOctober 18, 2021OsteoarthritisRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisGoutLupus & Connective Tissue Diseases
Adalimumab biosimilar Cyltezo gets interchangeability designationOctober 18, 2021Rheumatoid ArthritisSpondyloarthropathiesPediatricsPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Upadacitinib meets primary endpoints for improvement in ankylosing spondylitis and nonradiographic diseaseOctober 14, 2021SpondyloarthropathiesAnkylosing spondylitis
Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studiesSeptember 30, 2021Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitisLupus & Connective Tissue Diseases
Early vs. late TNFi switch in AS patients associated with different risk factorsSeptember 24, 2021Ankylosing spondylitisSpondyloarthropathies
Real-world data generate debate on definition of flare in axial spondyloarthritisSeptember 22, 2021SpondyloarthropathiesAnkylosing spondylitis
Targeting IL-23 could still be important for axial spondyloarthritis treatmentSeptember 20, 2021SpondyloarthropathiesAnkylosing spondylitis
European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
csDMARDs could add to TNF inhibitors’ benefits in SpASeptember 16, 2021SpondyloarthropathiesAnkylosing spondylitis
No gender gap seen in ankylosing spondylitis prevalence, study findsSeptember 7, 2021Ankylosing spondylitisSpondyloarthropathies
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisLupus & Connective Tissue Diseases
Researchers follow development of axial SpA in first-degree relatives of patientsJuly 7, 2021Ankylosing spondylitisSpondyloarthropathies
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitisJuly 1, 2021Psoriatic ArthritisMixed TopicsAnkylosing spondylitisSpondyloarthropathies
TNF inhibitors have delayed effect on spondyloarthritis radiographic progressionJune 11, 2021SpondyloarthropathiesAnkylosing spondylitis
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseasesMay 25, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
